Add BrightSurf on Google Email

Search results for “Huntingtons Disease”

1,000+ results for "Huntingtons Disease"

Predicting the progression of autoimmune disease with AI

A new AI model developed by researchers at Penn State College of Medicine can predict the progression of autoimmune disease among those with preclinical symptoms up to 1,000% more accurately. The GPS model integrates data from large genetic studies and electronic health records to identify individuals at high risk of disease progression.

SourcePenn State·JournalNature Communications·TypeComputational simulation/modeling·DateJan 7, 2025

Genes or environment? A new model for understanding disease risk factors

A new model developed by Penn State researchers more accurately predicts the causal relationship between genetic and environmental factors in disease development. The study found that lifestyle and environmental factors play a larger role than previously believed, offering new opportunities to mitigate disease risk.

SourcePenn State·JournalNature Communications·TypeData/statistical analysis·DateJul 30, 2024

Decoding early Lyme disease

Early Lyme disease can be difficult to diagnose due to its flu-like symptoms and the limitations of current testing methods. The new guidance article provides recommendations for clinicians to improve Lyme disease outcomes by assessing criteria for positivity and mitigating factors, as well as optimal timing of testing.

SourceRutgers University·JournalNEJM Evidence·TypeCommentary/editorial·DateJul 23, 2024

Study reveals racial disparities in Huntington’s disease diagnoses

A new study by UCLA Health reveals racial disparities in Huntington's disease diagnoses, with Black patients receiving diagnoses one year later than White patients. The study analyzed nearly 5,000 patient data points and found that these disparities may exacerbate underrepresentation of minority groups in clinical trials.

SourceUniversity of California - Los Angeles Health Sciences·JournalNeurology Clinical Practice·TypeData/statistical analysis·DateJul 9, 2024

New study reveals combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients

A new study led by Chapman University researchers found that combining Donepezil and Memantine significantly increased the probability of five-year survival for Alzheimer's disease patients. The combined use of these two medications reduced mortality rates by 0.05, or 6.4%, compared to no treatment and single-drug use.

SourceChapman University·JournalCommunications Medicine·DateJun 12, 2024

Study findings demonstrate benefit to pediatric celiac disease mass screening

The study, conducted by Children's Hospital Colorado, found improvements in symptoms and quality of life for children diagnosed with celiac disease after participating in a mass screening program. Mass screening for pediatric celiac disease may become more common in the US, following similar conclusions drawn from European studies.

SourceChildren's Hospital Colorado·JournalClinical Gastroenterology and Hepatology·TypeObservational study·DateMay 13, 2024

Genetic variations may predispose people to Parkinson’s disease following long-term pesticide exposure, study finds

A new study found that genetic variants in lysosomal genes may contribute to the development of Parkinson's disease in individuals exposed to high levels of pesticides. The research suggests a potential gene-environment interaction, where minor changes in these genes can lead to increased disease risk under stress.

SourceUniversity of California - Los Angeles Health Sciences·Journalnpj Parkinson s Disease·TypeRandomized controlled/clinical trial·DateApr 25, 2024

High-resolution images reveal similarities in protein structures between Alzheimer’s disease and Down syndrome

A new study found similarities in protein structures of Aβ and tau filaments between individuals with Alzheimer's disease and those with both conditions. This knowledge is crucial for understanding Alzheimer's disease in people with Down syndrome and assessing clinical trial inclusion.

SourceIndiana University School of Medicine·JournalNature Structural & Molecular Biology·DateMar 29, 2024

New treatment target identified for Alzheimer's disease

Researchers have identified PDE4B as a potential target for treating Alzheimer's disease, where reducing its activity shows promise in improving memory and glucose metabolism. The study suggests that this approach may also protect against other forms of dementia, such as Huntington's disease.

SourceLancaster University·JournalNeuropsychopharmacology·TypeExperimental study·DateMar 26, 2024

Simple measurement can predict risk of worsening of widespread kidney disease

A team of researchers from Aarhus University has developed a simple measurement of protein in the urine that can predict which individuals are at high risk of rapid progression of chronic kidney disease. The study found that patients with newly diagnosed mild to moderate chronic kidney disease within three years have a 15% risk of rapi...

SourceAarhus University·JournalNephrology Dialysis Transplantation·TypeExperimental study·DateFeb 26, 2024

Mount Sinai researchers identify diverse neuron types associated with vulnerability to Parkinson's disease

Researchers discovered a previously unreported neuron type with vulnerability in Parkinson's disease, shedding light on the complexity of the disease and potential therapeutic targets. The study identified distinct transcriptomic signatures of this neuron type and found reduced RIT2 expression in Parkinson's disease patients.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalScience Advances·TypeObservational study·DateJan 11, 2024

Coronary heart disease before age 45 may increase risk of dementia later in life

Research found a significant linear relationship between age of coronary heart disease onset and dementia, highlighting the detrimental influence of premature cardiovascular events on brain health. Adults diagnosed with coronary heart disease at a young age may be at increased risk of developing dementia, Alzheimer's disease, and vascu...

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateNov 29, 2023

Fatty liver disease patients likely to suffer from personality disorder

Researchers at the University of Birmingham found that individuals with fatty liver disease are three times more likely to have a personality disorder than those without. Lifestyle modifications, such as changes in diet and exercise, can prevent disease progression but often fail to be implemented due to mental health factors.

SourceUniversity of Birmingham·JournalBMC Gastroenterology·TypeData/statistical analysis·DateOct 2, 2023

New perspectives on MAFLD

A new set of diagnostic criteria for MAFLD has been developed, providing accurate and reliable diagnoses. This development has increased awareness of the disease and paved the way for further research and clinical trials, offering a significant step forward in diagnosing and treating MAFLD.

SourceFirst Hospital of Jilin University·JournaleGastroenterology·DateSep 16, 2023

Calculating disease risk in individuals with previous disease

A new study found that having a previous disease increases an individual's risk of developing another disease, regardless of age and established risk factors. The study analyzed data from the UK Biobank cohort and found roughly double the expected rate of new diseases in certain groups, such as high-BMI men who smoke.

SourcePNAS Nexus·JournalPNAS Nexus·DateSep 12, 2023

Lewy body disease can be detected before symptoms

Researchers at Lund University have developed a spinal fluid test to detect Lewy body disease before symptoms emerge. The study found that nearly ten percent of individuals without initial cognitive or motor difficulties had Lewy bodies in their brains, highlighting the potential for early detection and treatment.

SourceLund University·JournalNature Medicine·DateJul 18, 2023

Genomics- and image-guided subtyping refines characterization of Alzheimer’s disease

Researchers developed a computational technique combining genomic and tau PET imaging data to identify four subtypes of Alzheimer's disease. The integrated approach also revealed top genes associated with each subtype. This personalized diagnostic technique has potential for broad utility across various diseases.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateJun 26, 2023

Sickle cell disease is 11 times more deadly than previously recorded

A new study reveals sickle cell disease is far deadlier than its textbook description, with a total mortality burden of 373,000 deaths in 2021. The condition disproportionately affects children, adolescents, and young adults worldwide, highlighting the need for universal newborn screening and early intervention.

SourceInstitute for Health Metrics and Evaluation·JournalThe Lancet Haematology·TypeSystematic review·DateJun 15, 2023

University of Ottawa team leads promising new research on devastating brain disorder

A University of Ottawa team has discovered a vital role for the VGLUT3 transporter protein in modulating the development of Huntington's disease. The study shows that blocking glutamate release through this protein can lead to an amelioration of the disease progression, offering new hope for potential treatment approaches.

SourceUniversity of Ottawa·JournalNeurobiology of Disease·TypeExperimental study·DateJun 7, 2023

Patients with IBD at higher risk of lymphoma

Patients with inflammatory bowel disease (IBD) are at a higher risk of developing lymphoma, particularly those with Crohn's disease. The risk is driven by both the disease activity and treatment, including immunomodulating drugs.

SourceKarolinska Institutet·JournalClinical Gastroenterology and Hepatology·TypeObservational study·DateApr 13, 2023